China NT Pharma Group Company Limited (HKG:1011)
Hong Kong · Delayed Price · Currency is HKD 0.3700
-0.0050 (-1.33%)
Jul 30, 2026, 1:00 PM HKT
HKG:1011 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.22 | 9.62 | 1.52 | 5.93 | 9.44 |
Cash & Short-Term Investments | 7.22 | 9.62 | 1.52 | 5.93 | 9.44 |
Cash Growth | -24.96% | 533.09% | -74.37% | -37.19% | 22.73% |
Accounts Receivable | 1.8 | - | 10.05 | 33.67 | 12.45 |
Other Receivables | 0.1 | 0.08 | 0.55 | 20.78 | 21.52 |
Receivables | 1.9 | 0.08 | 10.6 | 54.45 | 33.98 |
Inventory | 0.4 | 0.17 | - | 10.32 | 32.01 |
Prepaid Expenses | 4.57 | 5.09 | 0.11 | - | - |
Other Current Assets | 1.27 | 1.23 | 0.05 | 2.74 | 192.28 |
Total Current Assets | 15.36 | 16.19 | 12.28 | 73.43 | 267.7 |
Property, Plant & Equipment | 0.63 | 0.54 | 0.94 | 379.72 | 222.37 |
Long-Term Investments | 331.36 | 317.28 | 313.55 | 277.58 | 278.46 |
Other Intangible Assets | - | - | 0.2 | 274.98 | 186.83 |
Other Long-Term Assets | - | 0.07 | 2.16 | - | - |
Total Assets | 347.35 | 334.08 | 329.12 | 1,006 | 955.36 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.66 | 0.5 | 0.97 | 8.48 | 44.63 |
Accrued Expenses | 133.25 | 143.99 | 118.64 | 170.56 | 100.1 |
Short-Term Debt | 252.52 | 313.81 | 286.09 | 348.07 | 140.45 |
Current Portion of Long-Term Debt | 63.61 | 53.69 | 54.62 | 476.97 | 476.38 |
Current Portion of Leases | 0.49 | 0.34 | 0.63 | 0.95 | 1.61 |
Current Income Taxes Payable | - | - | 0.12 | 25.05 | 13.98 |
Current Unearned Revenue | - | - | - | 4.8 | 6.1 |
Other Current Liabilities | 168.58 | 212.74 | 204.01 | 134.82 | 112.73 |
Total Current Liabilities | 621.1 | 725.07 | 665.09 | 1,170 | 895.97 |
Long-Term Debt | - | 7.99 | 3.22 | - | 213.29 |
Long-Term Leases | 0.09 | 0.13 | 0.38 | 0.46 | 0.39 |
Long-Term Deferred Tax Liabilities | - | - | - | 77.22 | 57.08 |
Total Liabilities | 621.18 | 733.18 | 668.69 | 1,247 | 1,167 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 1,891 | 1,806 | 1,806 | 1,759 | 1,759 |
Retained Earnings | -2,566 | -2,549 | -2,498 | -2,639 | -2,537 |
Comprehensive Income & Other | 401.12 | 343.89 | 351.98 | 638.24 | 566.86 |
Total Common Equity | -273.62 | -399.11 | -339.57 | -241.66 | -211.38 |
Minority Interest | -0.21 | - | - | - | - |
Shareholders' Equity | -273.83 | -399.11 | -339.57 | -241.66 | -211.38 |
Total Liabilities & Equity | 347.35 | 334.08 | 329.12 | 1,006 | 955.36 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 316.7 | 375.95 | 344.94 | 826.45 | 832.11 |
Net Cash (Debt) | -309.48 | -366.33 | -343.42 | -820.52 | -822.67 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.50 | -1.39 | -1.44 | -4.32 | -4.35 |
Filing Date Shares Outstanding | 674.25 | 264.09 | 264.09 | 190.46 | 190.46 |
Total Common Shares Outstanding | 674.25 | 264.09 | 264.09 | 190.46 | 190.46 |
Working Capital | -605.73 | -708.88 | -652.81 | -1,096 | -628.27 |
Book Value Per Share | -0.41 | -1.51 | -1.29 | -1.27 | -1.11 |
Tangible Book Value | -273.62 | -399.11 | -339.76 | -516.64 | -398.21 |
Tangible Book Value Per Share | -0.41 | -1.51 | -1.29 | -2.71 | -2.09 |
Buildings | - | - | - | 363.03 | 207.26 |
Machinery | 0.06 | 0.02 | 0.16 | 87.27 | 38.16 |
Construction In Progress | - | - | - | 5.83 | 1.5 |
Leasehold Improvements | 0.11 | - | - | 9.73 | 9.25 |